Maternal allo anti-M antibody-induced hemolytic disease of newborn

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hemolytic disease of the fetus and newborn is a syndrome associated with immune destruction of the fetal and newborn red cells by maternal red cell alloantibodies. The detection of anti-M in antenatal screening can be responsible for neonatal red cell aplasia. A 32-h-old full-term neonate admitted with inconsolable cry and mild fever. Laboratory tests revealed progressive anemia and hyperbilirubinemia on day 3. The peripheral blood smear showed evidence of hemolysis and reticulocyte count was reduced. Intensive phototherapy and antibiotics were started after ruling out other causes of hyperbilirubinemia. Blood group typing and advanced red cell serology workup were done. Antibody screening and identification was suggestive of the presence of anti-M antibody in both mother and baby. Intravenous immunoglobulin and red blood cell transfusions were given. Anti-M is capable of causing hemolytic disease of the fetus and newborn and prolonged anemia. Newborns with anemia should be evaluated for all the possible causes to establish a diagnosis.

Cite

CITATION STYLE

APA

Mathew, A. M., Shah, S., Bhatnagar, N., Shah, M., Patel, T., & Thakkar, T. (2022). Maternal allo anti-M antibody-induced hemolytic disease of newborn. Asian Journal of Transfusion Science, 16(1), 144–147. https://doi.org/10.4103/ajts.ajts_109_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free